Table 2 Relationship between PSMC2 expression and tumor characteristics in patients with breast cancer.

From: Overexpression of PSMC2 promotes the tumorigenesis and development of human breast cancer via regulating plasminogen activator urokinase (PLAU)

Features

No. of patients

PSMC2 expression

P value

Low

High

All patients

175

83

92

 

Age (years)

   

0.072

 ≤60

108

56

52

 

 >60

59

22

37

 

Tumor size

   

0.020

 ≤3 cm

87

45

42

 

 >3 cm

59

19

40

 

Grade

   

0.006

 I

1

0

1

 

 II

81

45

36

 

 III

67

21

46

 

T Infiltrate

   

0.347

 T1

42

22

20

 

 T2

100

45

55

 

 T3

14

5

9

 

 T4

1

1

0

 

Lymphatic metastasis (N)

   

0.238

 N0

85

37

48

 

 N1

42

19

23

 

 N2

21

12

9

 

 N3

12

7

5

 

AJCC Stage

   

0.637

 1

30

15

15

 

 2

88

37

51

 

 3

39

21

18

 

Lymphoid positive number

   

0.475

 =0

78

32

46

 

 >0

66

31

35

Â